NATIONWIDE CHILDREN S HOSPITAL INC has a total of 16 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are RAVEN BIOTECHNOLOGIES INC, NATIONWIDE CHILDRENS HOSPITAL and CENTELION.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials | |
#7 | Unspecified technologies | |
#8 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Bakaletz Lauren O | 8 |
#2 | Munson Jr Robert S | 4 |
#3 | Beall Clifford J | 2 |
#4 | Munson Robert S Jr | 2 |
#5 | Johnson Jr Philip R | 2 |
#6 | Clark Kelly R | 2 |
#7 | Dyer David | 1 |
#8 | Harper Scott Quenton | 1 |
#9 | Caldas Hannah | 1 |
#10 | Garg Vidu | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013059302A1 | Products and methods for aortic abdominal aneurysm | |
WO2012145597A2 | Recombinant virus products and methods for inhibition of expression of myotilin | |
US2011275566A1 | Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf) | |
US2009275138A1 | Production of rAAV in vero cells using particular adenovirus helpers | |
US2009239937A1 | Apoptosis-inducing genes for treating cancer |